MENLO PARK, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced its entry into the ...
Long-read genome sequencing is being integrated early into ASO therapy development to capture complex genetic variants missed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results